PharmaCyte Biotech Stock Price

-0.05 (-2.2%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 40,651
Bid Price 2.18
Ask Price 6.86
News -
Day High 2.30


52 Week Range


Day Low 2.18
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
PharmaCyte Biotech Inc PMCB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -2.2% 2.22 00:00:02
Open Price Low Price High Price Close Price Prev Close
2.30 2.18 2.30 2.22 2.27
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
271 40,651 $ 2.23 $ 90,838 - 1.79 - 9.98
Last Trade Time Type Quantity Stock Price Currency
16:00:01 1,117 $ 2.22 USD


Draw Mode:

PharmaCyte Biotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 46.00M 20.72M 20.67M $ - $ - -2.51 -1.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 2.80%

more financials information »

PharmaCyte Biotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PMCB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.062.302.05732.25123,7260.167.77%
1 Month2.052.371.962.18235,3050.178.29%
3 Months1.932.511.852.09423,8390.2915.03%
6 Months2.652.831.792.25357,747-0.43-16.23%
1 Year3.089.981.796.312,506,146-0.86-27.92%
3 Years3.089.981.796.312,506,146-0.86-27.92%
5 Years3.089.981.796.312,506,146-0.86-27.92%

PharmaCyte Biotech Description

PharmaCyte Biotech Inc is a clinical stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. It is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer killing drugs at the source of cancer.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.